Healthcare -
Biotechnology - NASDAQ - GB
$ 0.3
-0.892 %
$ 76.8 M
Market Cap
-1.0
P/E
ADAP - TOTAL RECEIVABLES
Total Receivables ADAP - Adaptimmune Therapeutics plc
16 M
LAST VALUE
46.61%
2 YEAR CAGR
-3.69%
5 YEAR CAGR
129.17%
10 YEAR CAGR